Niagen Bioscience wins FDA and EMA designations for A-T drug

July 13, 2026 8:32 AM

Niagen Bioscience, Inc. (NASDAQ: NAGE) announced that the U.S. Food and Drug Administration granted Rare Pediatric Disease designation to its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found